Detalles de la búsqueda
1.
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Trials;
22(1): 9, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407777
Resultados
1 -
1
de 1
1
Próxima >
>>